Metastatic Non-small Cell Lung Cancer With MTAP Deletion
specificA non-squamous non-small cell carcinoma that arises from the lung and has metastasized to another anatomic site.
11
Centers
11
Active Trials
—
Cancer Funding
Top Centers for Metastatic Non-small Cell Lung Cancer With MTAP Deletion(11)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 54.5 |
| 2 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive Active Research Program | 54.5 |
| 3 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 54.5 |
| 4 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program | 54.5 |
| 5 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 54.5 |
| 6 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 54.5 |
| 7 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program | 54.5 |
| 8 | Boston University Cancer CenterBoston, MA Active Research Program | 54.5 |
| 9 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 54.5 |
| 10 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program | 54.5 |
| 11 | University of Texas Medical Branch Cancer CenterGalveston, TX Active Research Program | 54.5 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →